Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north ...

When Din Bisevac took over as CEO of Buena, he steered it to top investor backing. Plus, a mental health chatbot and Ty Haney ...

Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for ...

The opinion will now be referred to the European Commission for final regulatory decision on donanemab  INDIANAPOLIS, July 25 ...

Ozzy Osbourne’s former mistress, Michelle Pugh, considered him the “greatest love” of her life after the years-long affair ...

New research shows that older women may be more at risk of harmful inflammation when receiving gene therapy for serious eye ...

A major scientific breakthrough has identified the Epstein-Barr virus (EBV) as the leading cause of multiple sclerosis (MS), ...

On this episode of “Uncanny Valley,” we dive into the heated race between two companies to build a commercial brain-computer interface.

On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a landmark initiative to phase out animal testing in ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.